Charles Schwab’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.4K | Hold |
12,000
| – | – | ﹤0.01% | 3462 |
|
|
2025
Q1 | $18.2K | Buy |
+12,000
| New | +$18.2K | ﹤0.01% | 3465 |
|
|
2024
Q2 | – | Sell |
-60,512
| Closed | -$175K | – | 3651 |
|
|
2024
Q1 | $175K | Hold |
60,512
| – | – | ﹤0.01% | 3253 |
|
|
2023
Q4 | $445K | Hold |
60,512
| – | – | ﹤0.01% | 3117 |
|
|
2023
Q3 | $465K | Buy |
60,512
+5,472
| +10% | +$42K | ﹤0.01% | 3061 |
|
|
2023
Q2 | $558K | Buy |
+55,040
| New | +$558K | ﹤0.01% | 2998 |
|
|
2022
Q2 | – | Sell |
-45,441
| Closed | -$295K | – | 3591 |
|
|
2022
Q1 | $295K | Buy |
45,441
+24,044
| +112% | +$156K | ﹤0.01% | 3216 |
|
|
2021
Q4 | $346K | Buy |
21,397
+1,161
| +6% | +$18.8K | ﹤0.01% | 3258 |
|
|
2021
Q3 | $538K | Buy |
+20,236
| New | +$538K | ﹤0.01% | 3123 |
|